1、Cite Score(2024年最新版) CiteScore:5.5 SJR:1.174 SNIP:1.033 学科类别分区排名百分位 大类:Medicine小类:Radiology, Nuclear Medicine and ImagingQ181 / 333 75% 大类:Medicine小类:OncologyQ2145 / 404 64% 大类:Medicine小类:Cancer ResearchQ3120 / 230 ...
Journal Abbreviation: CANCER RES Journal ISSN: 0008-5472 YearImpact Factor (IF)Total ArticlesTotal Cites 2023 (2024 update)12.5253122978 202211.2-141481 202113.312-161957 202012.701453159236 20199.727536135753 20188.378555130932 20179.130632139291 20169.122648139655 ...
Year Impact Factor (IF) Total Articles Total Cites 2023 (2024 update) 3.4 - - 2022 3.8 - 46702 2021 4.638 - 46148 2020 4.430 1196 41517 2019 3.150 1240 30109 2018 2.933 1282 25843 2017 3.288 889 24272 2016 3.288 891 21145 2015 3.265 1019 17676 2014 3.362 981 15227 2013 3.319 616 ...
聚焦肺癌和消化道肿瘤,复宏汉霖积极推进H药与公司其他产品的协同以及与创新疗法的联合,在全球同步开展10余项肿瘤免疫联合疗法临床试验,于中国、美国、土耳其、波兰、格鲁吉亚等国家和地区累计入组超3600人。H药的4项关键性临床研究结果分别...
BMC Cancer: Open access journal for cancer research, with 3.4 Impact Factor and 12 days to first decision. BMC Cancer is an open access, peer-reviewed ...
Those conceptual gains are steadily being converted into actual gains in the practice of cancer diagnosis and treatment, with notable progress toward personalized cancer medicine, in which therapy is tailored to individuals according to biological anomalies unique to their disease. Personalized cancer ...
Research Impact Score*: 7.6 Citescore: 20.7 SCIMAGO SJR: 2.413 SCIMAGO H-index: 107 Research Ranking (Medicine) 625 Research Ranking (Medicine) 445 Number of Best scientists*: 141 Documents by best scientists*: 173 Journal Information ISSN: 0392-9078 Publisher: Editors-in-Chief...
Research Impact Score*: 5.3 Impact Factor: 4 SCIMAGO SJR: 1.318 SCIMAGO H-index: 62 Research Ranking (Medicine) 734 Number of Best scientists*: 156 Documents by best scientists*: 282 Journal Information ISSN: 2218-6751 Publisher: Editors-in-Chief: Caicun Zhou , Rafael Rosell ...
20 June 2024|Open Access In vivo CRISPR screens reveal SCAF1 and USP15 as drivers of pancreatic cancer Functional characterization of genetic alterations is a prerequisite for pancreatic cancer precision medicine. Here, using in vivo CRISPR screens, the authors integrate human cancer genomics and mous...
ResearchOpen access13 November 2024Article: 22 Journal updates Cancer Immunology, Immunotherapy is now fully open access! We are excited to announce thatCancer Immunology, Immunotherapyhas now become a fully open-access (OA) journal as of 5thJanuary 2024. This means that we will only be publishing...